ANTI-CXCR3 ANTIBODIES AND METHODS OF USE THEREOF
The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | Lodie Tracey Chu Ruiyin Youd Michele Tedstone Jennifer Carter Karen B Connors Timothy D Pinckney Jason Robert Masterjohn Elizabeth |
| description | The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2018086838A1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2018086838A1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2018086838A13</originalsourceid><addsrcrecordid>eNrjZDBw9Avx1HWOcA4yVgAxnfxdPF2DgUwXBV_XEA9_l2AFfzeF0GBXhRAP1yBXfzceBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGhhYGFmYWzhaGhMnCoAoJMm9w</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>ANTI-CXCR3 ANTIBODIES AND METHODS OF USE THEREOF</title><source>esp@cenet</source><creator>Lodie Tracey ; Chu Ruiyin ; Youd Michele ; Tedstone Jennifer ; Carter Karen B ; Connors Timothy D ; Pinckney Jason Robert ; Masterjohn Elizabeth</creator><creatorcontrib>Lodie Tracey ; Chu Ruiyin ; Youd Michele ; Tedstone Jennifer ; Carter Karen B ; Connors Timothy D ; Pinckney Jason Robert ; Masterjohn Elizabeth</creatorcontrib><description>The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.</description><language>eng</language><subject>CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><creationdate>2018</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180329&DB=EPODOC&CC=US&NR=2018086838A1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,777,882,25545,76296</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20180329&DB=EPODOC&CC=US&NR=2018086838A1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>Lodie Tracey</creatorcontrib><creatorcontrib>Chu Ruiyin</creatorcontrib><creatorcontrib>Youd Michele</creatorcontrib><creatorcontrib>Tedstone Jennifer</creatorcontrib><creatorcontrib>Carter Karen B</creatorcontrib><creatorcontrib>Connors Timothy D</creatorcontrib><creatorcontrib>Pinckney Jason Robert</creatorcontrib><creatorcontrib>Masterjohn Elizabeth</creatorcontrib><title>ANTI-CXCR3 ANTIBODIES AND METHODS OF USE THEREOF</title><description>The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.</description><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2018</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZDBw9Avx1HWOcA4yVgAxnfxdPF2DgUwXBV_XEA9_l2AFfzeF0GBXhRAP1yBXfzceBta0xJziVF4ozc2g7OYa4uyhm1qQH59aXJCYnJqXWhIfGmxkYGhhYGFmYWzhaGhMnCoAoJMm9w</recordid><startdate>20180329</startdate><enddate>20180329</enddate><creator>Lodie Tracey</creator><creator>Chu Ruiyin</creator><creator>Youd Michele</creator><creator>Tedstone Jennifer</creator><creator>Carter Karen B</creator><creator>Connors Timothy D</creator><creator>Pinckney Jason Robert</creator><creator>Masterjohn Elizabeth</creator><scope>EVB</scope></search><sort><creationdate>20180329</creationdate><title>ANTI-CXCR3 ANTIBODIES AND METHODS OF USE THEREOF</title><author>Lodie Tracey ; Chu Ruiyin ; Youd Michele ; Tedstone Jennifer ; Carter Karen B ; Connors Timothy D ; Pinckney Jason Robert ; Masterjohn Elizabeth</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2018086838A13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2018</creationdate><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><toplevel>online_resources</toplevel><creatorcontrib>Lodie Tracey</creatorcontrib><creatorcontrib>Chu Ruiyin</creatorcontrib><creatorcontrib>Youd Michele</creatorcontrib><creatorcontrib>Tedstone Jennifer</creatorcontrib><creatorcontrib>Carter Karen B</creatorcontrib><creatorcontrib>Connors Timothy D</creatorcontrib><creatorcontrib>Pinckney Jason Robert</creatorcontrib><creatorcontrib>Masterjohn Elizabeth</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>Lodie Tracey</au><au>Chu Ruiyin</au><au>Youd Michele</au><au>Tedstone Jennifer</au><au>Carter Karen B</au><au>Connors Timothy D</au><au>Pinckney Jason Robert</au><au>Masterjohn Elizabeth</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>ANTI-CXCR3 ANTIBODIES AND METHODS OF USE THEREOF</title><date>2018-03-29</date><risdate>2018</risdate><abstract>The present disclosure provides anti-CXCR3 antibodies and methods of using the antibodies to diagnose and/or treat CXCR3-associated disorders such as diabetes mellitus type I (T1D), particularly new-onset T1D. In certain embodiments, disclosed herein are CXCR3 neutralizing antibodies.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2018086838A1 |
| source | esp@cenet |
| subjects | CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES |
| title | ANTI-CXCR3 ANTIBODIES AND METHODS OF USE THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-19T13%3A54%3A11IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=Lodie%20Tracey&rft.date=2018-03-29&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2018086838A1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |